Who
TPG GP A, LLC
10% owner
Company insider
Files Form 4 as: 10% owner, LifeStance Health Group; Other, CeriBell; Other, Odyssey Therapeutics; 10% owner, TPG Twin Brook Capital Income Fund; 10% owner, Sionna Therapeutics; Other, TPG RE Finance Trust; 10% owner, Life Time Group Holdings; 10% owner and Other, Cushman & Wakefield.
In numbers
- Trades disclosed
- 34
- Buys
- 3
- Sells
- 14
- Bought
- $55.2M
- Sold
- $2.0B
- Companies
- 12
- Companies where not an officer
- 12
- First trade
- 31 May 2022
- Last trade
- 11 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 15 Sep 2026 | LFST LifeStance Health GroupProviders & Facilities | SEC FORM 4 Sold | $226.3M18,409,705 at $12.29 | filing |
| 11 Sep 2026filed 15 Sep 2026 | LFST LifeStance Health GroupProviders & Facilities | SEC FORM 4 Sold | $226.3M18,409,705 at $12.29 | filing |
| 10 Aug 2026filed 12 Aug 2026 | LFST LifeStance Health GroupProviders & Facilities | SEC FORM 4 Sold | $144.9M13,643,207 at $10.62 | filing |
| 10 Aug 2026filed 12 Aug 2026 | LFST LifeStance Health GroupProviders & Facilities | SEC FORM 4 Sold | $144.9M13,643,207 at $10.62 | filing |
| 26 Jun 2026filed 30 Jun 2026 | CBLL CeriBellMedical Devices | SEC FORM 4 Sold | $4.1M202,368 at $20.12 | filing |
| 12 May 2026filed 14 May 2026 | LFST LifeStance Health GroupProviders & Facilities | SEC FORM 4 Sold | $226.8M28,281,943 at $8.02 | filing |
| 12 May 2026filed 14 May 2026 | LFST LifeStance Health GroupProviders & Facilities | SEC FORM 4 Sold | $226.8M28,281,943 at $8.02 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Code J | —423,111 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Code J | $42K2,351 at $18.00 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,880,497 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Bought | $25.0M1,388,889 at $18.00 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code J | —423,111 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —18,272,789 | filing |
| 2 Mar 2026filed 4 Mar 2026 | LFST LifeStance Health GroupProviders & Facilities | SEC FORM 4 Sold | $145.0M20,685,061 at $7.01 | filing |
| 2 Mar 2026filed 4 Mar 2026 | LFST LifeStance Health GroupProviders & Facilities | SEC FORM 4 Sold | $145.0M20,685,061 at $7.01 | filing |
| 29 Jan 2026filed 2 Feb 2026 | TPG Twin Brook Capital Income Fund | SEC FORM 4 Bought | $10.0M396,912.02 at $25.19 | filing |
| 22 Jan 2026filed 26 Jan 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Sold | $10.0M250,000 at $40.00 | filing |
| 5 Aug 2025filed 7 Aug 2025 | TRTX TPG RE Finance TrustREITs | SEC FORM 4 Code J | —4,693,916 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | LTH Life Time Group HoldingsEntertainment, Gaming & Leisure Services | SEC FORM 4 Sold | $212.9M7,067,299 at $30.13 | filing |
| 10 Feb 2025filed 12 Feb 2025 | SION Sionna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,276,276 | filing |
News
Odyssey Therapeutics Announces Encouraging Phase 2a Ulcerative Colitis ResultsODTX · rttnews.com · 20 Oct 2026Financial Comparison: CeriBell (NASDAQ:CBLL) and LogicMark (OTCMKTS:LGMKD)CBLL · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name TPG GP A, LLC; 2 articles from the last 14 days about the 4 companies they traded most, at most three about any one of them.